Kenya vs Sri Lanka: Treatment success rate for patients treated for MDR-TB
Kenya
79.0%
in 2022
Sri Lanka
79.0%
in 2022
Kenya rank
56th
Sri Lanka rank
56th
Treatment success rate for patients treated for MDR-TB over time
- Kenya
- Sri Lanka
How they compare
Kenya currently reports 79.0% against 79.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 7 times across 17 shared years of data; in 2006 it was Kenya ahead.
Kenya ranks 56th and Sri Lanka ranks 56th of 163 countries.
Across the 3 decades both report, Kenya averaged higher in 2 and Sri Lanka in 1.
Head to head by decade
| Decade | Kenya | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.8% | 31.5% | 43.2% | Kenya |
| 2010s | 74.7% | 75.6% | 0.9% | Sri Lanka |
| 2020s | 78.0% | 56.0% | 22.0% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kenya or Sri Lanka?
- Kenya, at 79.0% against 79.0% in Sri Lanka as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kenya and Sri Lanka?
- 0.0%, with Kenya ahead.
- How many years of comparable data are there for Kenya and Sri Lanka?
- 17 years are reported by both, from 2006 to 2022.
- How do Kenya and Sri Lanka rank globally for treatment success rate for patients treated for mdr-tb?
- Kenya ranks 56th and Sri Lanka ranks 56th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.